Skip to Main content Skip to Navigation
Journal articles

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin

Matthieu Million 1 Audrey Giraud-Gatineau 2 Jean-Christophe Lagier 1 Philippe Parola 2 Philippe Gautret 2 Didier Raoult 1 
1 MEPHI - Microbes évolution phylogénie et infections
2 VITROME - Vecteurs - Infections tropicales et méditerranéennes
Document type :
Journal articles
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-03211439
Contributor : Isabelle COMBE Connect in order to contact the contributor
Submitted on : Wednesday, April 28, 2021 - 5:00:09 PM
Last modification on : Friday, April 1, 2022 - 3:57:13 AM

Links full text

pubmedcentral

Identifiers

Collections

CNRS | UNIV-AMU | INCIAM

Citation

Matthieu Million, Audrey Giraud-Gatineau, Jean-Christophe Lagier, Philippe Parola, Philippe Gautret, et al.. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Medicine and Infectious Disease, Elsevier, 2021, 39, pp.101954. ⟨10.1016/j.tmaid.2020.101954⟩. ⟨hal-03211439⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

9